Segal Institute for Clinical Research Physician, Steven E. Chavoustie, MD, FACOG, CCRP Co-authors Titan Pharmaceuticals Buprenorphine Implant Abstract

Published: Dec 20, 2012

MIAMI--(BUSINESS WIRE)--Segal Institute for Clinical Research, a consortium of psychiatric, addiction, medical and women’s health research sites, proudly congratulates Dr. Steven Chavousite for his co-authorship of the Titan Pharmaceuticals poster abstract, “Buprenorphine Implants for the Treatment of Opioid Dependence: Six and 12 Month Outcomes.”

Back to news